A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The Torcetrapib project was terminated on December 2, 2006 due to safety findings.
Cholesterol levels will be measured over six weeks in subjects being treated with two
different kinds of combination cholesterol medications to see how the different treatments
compare to one another.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Atorvastatin Atorvastatin Calcium Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin Torcetrapib